Theravance Biopharma, Inc. Quarterly Return On Equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Theravance Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2014 to Q3 2024.
  • Theravance Biopharma, Inc. Return On Equity for the quarter ending September 30, 2024 was -24.8 %, a 45.4% decline year-over-year.
  • Theravance Biopharma, Inc. annual Return On Equity for 2023 was -19.9 %, a 101% decline from 2022.
  • Theravance Biopharma, Inc. annual Return On Equity for 2022 was 1.58K %, a 2542% increase from 2021.
  • Theravance Biopharma, Inc. annual Return On Equity for 2021 was 59.7 %, a 50.3% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -24.8 -7.74 -45.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -21.3 -242 -110% Apr 1, 2024 Jun 30, 2024
Q1 2024 -19 -390 -105% Jan 1, 2024 Mar 31, 2024
Q4 2023 -19.9 -1.6K -101% Oct 1, 2023 Dec 31, 2023
Q3 2023 -17.1 +591 +97.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 221 +191 +642% Apr 1, 2023 Jun 30, 2023
Q1 2023 372 +327 +738% Jan 1, 2023 Mar 31, 2023
Q4 2022 1.58K +1.52K +2542% Oct 1, 2022 Dec 31, 2022
Q3 2022 -608 -678 -976% Jul 1, 2022 Sep 30, 2022
Q2 2022 29.8 -55.5 -65.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 44.4 -51.9 -53.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 59.7 -60.4 -50.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 69.4 -65.5 -48.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 85.3 -55.5 -39.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 96.3 -44.4 -31.6% Jan 1, 2021 Mar 31, 2021
Q4 2020 120 -23.8 -16.5% Oct 1, 2020 Dec 31, 2020
Q3 2020 135 -47.5 -26% Jul 1, 2020 Sep 30, 2020
Q2 2020 141 -141 -50% Apr 1, 2020 Jun 30, 2020
Q1 2020 141 -479 -77.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 144 +2.78K Oct 1, 2019 Dec 31, 2019
Q3 2019 182 +688 Jul 1, 2019 Sep 30, 2019
Q2 2019 282 +543 Apr 1, 2019 Jun 30, 2019
Q1 2019 620 +809 Jan 1, 2019 Mar 31, 2019
Q4 2018 -2.63K -2.49K -1823% Oct 1, 2018 Dec 31, 2018
Q3 2018 -506 -406 -409% Jul 1, 2018 Sep 30, 2018
Q2 2018 -262 -183 -232% Apr 1, 2018 Jun 30, 2018
Q1 2018 -189 -121 -179% Jan 1, 2018 Mar 31, 2018
Q4 2017 -137 -73.7 -117% Oct 1, 2017 Dec 31, 2017
Q3 2017 -99.4 -38.3 -62.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -78.7 -7.95 -11.2% Apr 1, 2017 Jun 30, 2017
Q1 2017 -67.7 +7.96 +10.5% Jan 1, 2017 Mar 31, 2017
Q4 2016 -63.1 +8.87 +12.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 -61.1 +15.1 +19.8% Jul 1, 2016 Sep 30, 2016
Q2 2016 -70.8 +0.24 +0.34% Apr 1, 2016 Jun 30, 2016
Q1 2016 -75.7 -8.29 -12.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -72 +23.2 +24.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -76.2 +49.6 +39.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -71 Apr 1, 2015 Jun 30, 2015
Q1 2015 -67.4 Jan 1, 2015 Mar 31, 2015
Q4 2014 -95.2 Oct 1, 2014 Dec 31, 2014
Q3 2014 -126 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.